Clinical and ethical issues in the treatment of a Jehovah's Witness with acute myeloblastic leukemia

I Kerridge; M Lowe; M Seldon; A Enno; S Deveridge

Clinical and ethical issues in the treatment of a Jehovah's Witness with acute myeloblastic leukemia

Arch Intern Med. 1997 Aug;157(15):1753-7.

Authors

I Kerridge¹, M Lowe, M Seldon, A Enno, S Deveridge

Affiliation

¹ Health Law and Ethics Program, University of Newcastle, Australia.

PMID: 9250237

Abstract

We report the first documented case of the use of peripheral blood stem cell autografting in the treatment of a Jehovah's Witness with acute myeloblastic leukemia. This case illustrates the complex ethical and clinical issues that arise in the treatment of such patients.

Publication types

Case Reports
Review

MeSH terms

Adult
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Christianity*
Ethics, Medical*
Humans
Jehovah's Witnesses*
Leukemia, Myeloid, Acute / blood
Leukemia, Myeloid, Acute / drug therapy*
Leukocyte Count
Male
Minors
Personal Autonomy
Platelet Count
Remission Induction